Clinical trial
Heme Iron Polypeptide for Iron Deficiency Anemia in Chronic Renal Failure
NCT00318812 · Ottawa Hospital Research Institute, Other · Completed
Key facts
| NCT number | NCT00318812 |
|---|---|
| Title | Heme Iron Polypeptide for Iron Deficiency Anemia in Chronic Renal Failure |
| Official title | Heme Iron Polypeptide for the Treatment of Iron Deficiency Anemia in Pre-Dialysis Patients: A Pilot Randomized Controlled Study |
| Lead sponsor | Ottawa Hospital Research Institute, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Anemia, Renal Failure |
| Intervention type | Drug |
| Interventions | Heme Iron Polypeptide (Proferrin), Iron sucrose (Venofer) |
| Enrollment | 55 |
| Start date | May 1, 2007 |
| Primary completion | Dec 1, 2011 |
| Completion | Dec 1, 2011 |
| First posted | Apr 27, 2006 |
| Last update posted | May 10, 2016 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: